Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$183M |
| 3 |
Meta Platforms (Facebook)
META
|
+$179M |
| 4 |
PepsiCo
PEP
|
+$149M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$243M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$163M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$85.5M |
| 4 |
SFR
Starwood Waypoint Homes
SFR
|
+$45.3M |
| 5 |
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
|
+$42.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Financials | 16.38% |
| 3 | Healthcare | 13.22% |
| 4 | Industrials | 10.47% |
| 5 | Consumer Discretionary | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNBC
2601
DELISTED
Sun Bancorp Inc
SNBC
| $2.43M | ﹤0.01% |
100,023
-390
| -0.4% | -$9.77K |
|
2602
Geron
GERN
$1.04B
| $2.42M | ﹤0.01% |
1,344,758
+25,058
| +2% | +$50.6K |
|
2603
Forestar Group
FOR
$1.49B
| $2.42M | ﹤0.01% |
109,774
-630,520
| -85% | -$12.3M |
|
|
CTO
2604
CTO Realty Growth
CTO
$816M
| $2.41M | ﹤0.01% |
139,657
+369
| +0.3% | +$6.03K |
|
2605
Rockwell Medical
RMTI
$28M
| $2.41M | ﹤0.01% |
3,760
+50
| +1% | +$35.2K |
|
2606
Winmark
WINA
$1.31B
| $2.41M | ﹤0.01% |
18,594
-260
| -1% | -$34.4K |
|
|
CIVI
2607
DELISTED
Civitas Solutions, Inc.
CIVI
| $2.4M | ﹤0.01% |
140,557
+5,039
| +4% | +$93.7K |
|
|
TSG
2608
DELISTED
The Stars Group Inc.
TSG
| $2.4M | ﹤0.01% |
103,247
-1,156
| -1% | -$25.2K |
|
2609
Mitek Systems
MITK
$834M
| $2.4M | ﹤0.01% |
268,251
+3,873
| +1% | +$35.3K |
|
|
LTS
2610
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $2.39M | ﹤0.01% |
756,532
+11,370
| +2% | +$35.3K |
|
2611
Capital City Bank Group
CCBG
$891M
| $2.39M | ﹤0.01% |
104,031
+1,345
| +1% | +$32.6K |
|
2612
Seneca Foods Class A
SENEA
$1.23B
| $2.38M | ﹤0.01% |
77,404
+196
| +0.3% | +$6.5K |
|
|
BRG
2613
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $2.38M | ﹤0.01% |
235,419
+1,376
| +0.6% | +$15.3K |
|
|
CAF
2614
Morgan Stanley China A Share Fund
CAF
$328M
| $2.37M | ﹤0.01% |
101,394
+14,168
| +16% | +$339K |
|
2615
Lineage Cell Therapeutics
LCTX
$286M
| $2.37M | ﹤0.01% |
1,259,416
+39,047
| +3% | +$85.3K |
|
|
RSO
2616
DELISTED
Resource Capital Corp.
RSO
| $2.37M | ﹤0.01% |
252,543
+4,561
| +2% | +$45.6K |
|
|
INSY
2617
DELISTED
Insys Therapeutics, Inc.
INSY
| $2.36M | ﹤0.01% |
245,665
-11,653
| -5% | -$76.3K |
|
|
ZIXI
2618
DELISTED
Zix Corporation
ZIXI
| $2.36M | ﹤0.01% |
538,444
+21,096
| +4% | +$99.3K |
|
2619
Diageo
DEO
$52.1B
| $2.34M | ﹤0.01% |
16,053
+306
| +2% | +$42.2K |
|
|
NXJ
2620
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
| $2.34M | ﹤0.01% |
170,853
+93,051
| +120% | +$1.28M |
|
2621
National Bankshares
NKSH
$269M
| $2.34M | ﹤0.01% |
51,435
+105
| +0.2% | +$4.76K |
|
|
REV
2622
DELISTED
Revlon, Inc.
REV
| $2.32M | ﹤0.01% |
106,617
+1,076
| +1% | +$23.8K |
|
|
CALA
2623
DELISTED
Calithera Biosciences, Inc
CALA
| $2.31M | ﹤0.01% |
13,818
-823
| -6% | -$211K |
|
2624
Vera Bradley
VRA
$94.1M
| $2.3M | ﹤0.01% |
189,140
-33,307
| -15% | -$301K |
|
|
GRFS
2625
Grifois
GRFS
$5.39B
| $2.3M | ﹤0.01% |
100,339
+4,551
| +5% | +$101K |
|
Similar funds
Geode Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Geode Capital Management held 4,142 positions worth $294B, up 8.7% from $271B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Geode Capital Management's Q4 2017 filing shows 98 new, 2,556 increased, 827 reduced and 120 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 742,921 shares worth $39M. The largest sale was CR Bard Inc., an estimated $243M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 742,921 shares worth $39M.
- Geode Capital Management added most to Apple in Q4 2017, an estimated $227M increase.
- Geode Capital Management's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $23.7M.
- Geode Capital Management fully exited CR Bard Inc. in Q4 2017, selling an estimated $243M.
- Geode Capital Management's ten largest holdings make up 17% of its $294B portfolio in Q4 2017.
- Geode Capital Management opened 98 new positions and closed 120 in Q4 2017.
- Geode Capital Management's portfolio value rose 8.7% quarter-over-quarter to $294B.
Based on Geode Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.